Old Web
English
Sign In
Acemap
>
authorDetail
>
Per Nyström
Per Nyström
AstraZeneca
Medicine
Ximelagatran
Anesthesia
Direct thrombin inhibitor
Anticoagulant
7
Papers
672
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Ximelagatran in Young Healthy Japanese Men
2006
Clinical Pharmacokinectics
Linda Wernevik
Per Nyström
Gillis Johnsson
Takashi Nakanishi
Ulf G. Eriksson
Show All
Source
Cite
Save
Citations (6)
Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long‐term secondary prevention of venous thromboembolism
2006
British Journal of Haematology
Karin Wåhlander
Henry Eriksson
Torbjörn Lundström
Solveig Billing Clason
Ulrika Wall
Per Nyström
Peter Wessman
Sam Schulman
Thrive Iii Investigators
Show All
Source
Cite
Save
Citations (14)
Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
2005
JAMA
Jean-Noel Fiessinger
Menno V. Huisman
Bruce L. Davidson
Henri Bounameaux
Charles W. Francis
Henry Eriksson
Torbjörn Lundström
Scott D. Berkowitz
Per Nyström
Mona Thorsén
Jeffrey S. Ginsberg
Show All
Source
Cite
Save
Citations (284)
1